common.study.topics.clinical

Biomarker for Premotor Parkinson's Disease

common.study.values.description

Ultra High Field Magnetic Resonance Imaging as a Biomarker for Premotor Parkinson's Disease

This is a prospective observational study investigating the utility of 7 Tesla MRI to quantify nigrosome1 signal in a cohort of individuals with recent onset Parkinson's disease and in at-risk cohorts at a premotor state of Parkinson's disease.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

MRI

participant.views.study.view.additional

participant.views.study.view.scientific-title

Ultra High Field Magnetic Resonance Imaging as a Biomarker for Premotor Parkinson's Disease

common.study.values.clinical-trial-id

NCT03288909

participant.views.study.view.id

YerDwb